Intuitive Surgical, Inc.'s (NASDAQ:ISRG) Stock Is Going Strong: Is the Market Following Fundamentals?
Intuitive Surgical, Inc.'s (NASDAQ:ISRG) Stock Is Going Strong: Is the Market Following Fundamentals?
Most readers would already be aware that Intuitive Surgical's (NASDAQ:ISRG) stock increased significantly by 10% over the past three months. Given that the market rewards strong financials in the long-term, we wonder if that is the case in this instance. Specifically, we decided to study Intuitive Surgical's ROE in this article.
大多數讀者可能已經知道 直覺外科公司的 (納斯達克:ISRG) 股票在過去三個月內顯著上漲了10%。鑑於市場在長期內獎勵強勁的財務表現,我們想知道在這種情況下是否也是如此。具體來說,我們決定在這篇文章中研究 直覺外科公司的 ROE。
Return on equity or ROE is an important factor to be considered by a shareholder because it tells them how effectively their capital is being reinvested. In simpler terms, it measures the profitability of a company in relation to shareholder's equity.
股本回報率或ROE是股東需要考慮的重要因素,因爲它告訴他們自己的資本是如何有效地被再投資的。簡單來說,它衡量的是公司相對於股東權益的盈利能力。
How To Calculate Return On Equity?
如何計算股東權益回報率?
The formula for return on equity is:
股東權益回報率的公式是:
Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity
股東權益回報率 = 淨利潤(來自持續運營)÷ 股東權益
So, based on the above formula, the ROE for Intuitive Surgical is:
因此,基於上述公式, 直覺外科公司的 ROE 爲:
14% = US$2.3b ÷ US$16b (Based on the trailing twelve months to September 2024).
14% = 230000000000美元 ÷ 160000000000美元(基於截至2024年9月的過去十二個月)。
The 'return' is the yearly profit. One way to conceptualize this is that for each $1 of shareholders' capital it has, the company made $0.14 in profit.
'回報'是年度利潤。一種理解方式是,對於每1美元的股東資本,公司賺取了0.14美元的利潤。
Why Is ROE Important For Earnings Growth?
ROE爲什麼對淨利潤增長很重要?
So far, we've learned that ROE is a measure of a company's profitability. Depending on how much of these profits the company reinvests or "retains", and how effectively it does so, we are then able to assess a company's earnings growth potential. Generally speaking, other things being equal, firms with a high return on equity and profit retention, have a higher growth rate than firms that don't share these attributes.
到目前爲止,我們已經了解到ROE是衡量公司盈利能力的指標。根據公司將這些利潤再投資或 "保留" 的程度,以及其有效性,我們能夠評估公司的盈利增長潛力。一般來說,其他條件相同的情況下,具有高回報率和利潤保留的公司,其增長率通常高於那些沒有這些屬性的公司。
Intuitive Surgical's Earnings Growth And 14% ROE
直覺外科公司的收益增長和14%的ROE
To start with, Intuitive Surgical's ROE looks acceptable. And on comparing with the industry, we found that the the average industry ROE is similar at 12%. Consequently, this likely laid the ground for the decent growth of 9.8% seen over the past five years by Intuitive Surgical.
首先,直覺外科公司的ROE看起來是可以接受的。與行業相比,我們發現行業的平均ROE相似,爲12%。因此,這可能爲直覺外科公司過去五年中9.8%的可觀增長奠定了基礎。
As a next step, we compared Intuitive Surgical's net income growth with the industry and found that the company has a similar growth figure when compared with the industry average growth rate of 12% in the same period.
作爲下一步,我們將直覺外科公司的淨利潤增長與行業進行了比較,發現該公司的增長數字與同期行業平均增長率12%相似。
The basis for attaching value to a company is, to a great extent, tied to its earnings growth. What investors need to determine next is if the expected earnings growth, or the lack of it, is already built into the share price. This then helps them determine if the stock is placed for a bright or bleak future. If you're wondering about Intuitive Surgical's's valuation, check out this gauge of its price-to-earnings ratio, as compared to its industry.
對公司的估值基礎在很大程度上與其盈利增長相關。投資者接下來需要判斷的是,預期的盈利增長或缺乏增長是否已經反映在股票價格中。這可以幫助他們判斷該股票的未來是光明還是暗淡。如果你在思考直覺外科公司的估值,可以查看其市盈率與行業的比較。
Is Intuitive Surgical Efficiently Re-investing Its Profits?
直覺外科公司是否有效地再投資其利潤?
Intuitive Surgical doesn't pay any regular dividends currently which essentially means that it has been reinvesting all of its profits into the business. This definitely contributes to the decent earnings growth number that we discussed above.
目前,直覺外科公司並未支付任何定期分紅,這基本意味着該公司將所有利潤再投資於業務。這確實爲我們之前討論的可觀盈利增長數字做出了貢獻。
Summary
總結
In total, we are pretty happy with Intuitive Surgical's performance. In particular, it's great to see that the company is investing heavily into its business and along with a high rate of return, that has resulted in a sizeable growth in its earnings. We also studied the latest analyst forecasts and found that the company's earnings growth is expected be similar to its current growth rate. Are these analysts expectations based on the broad expectations for the industry, or on the company's fundamentals? Click here to be taken to our analyst's forecasts page for the company.
總的來說,我們對直覺外科公司的表現很滿意。特別是看到公司在其業務上進行大量投資,同時又有高回報率,這導致了其盈利的顯著增長。我們還研究了最新的分析師預測,並發現公司的盈利增長預計與其當前增長率相似。這些分析師的預期是基於行業的普遍預期,還是基於公司的基本面?點擊這裏訪問我們爲該公司的分析師預測頁面。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
對本文有反饋?對內容有疑慮?請直接與我們聯繫。或者,發送電子郵件至 editorial-team (at) simplywallst.com。
這篇來自Simply Wall St的文章是一般性的。我們根據歷史數據和分析師預測提供評論,採用無偏見的方法,我們的文章並不旨在提供財務建議。它不構成對任何股票的買入或賣出建議,也未考慮到您的目標或財務狀況。我們旨在爲您提供以基本數據驅動的長期分析。請注意,我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St在提到的任何股票中均沒有持倉。
譯文內容由第三人軟體翻譯。